THE DEVELOPMENT OF ELECTRORETINOGRAM ABNORMALITIES AND THE POSSIBLE ROLE OF POLYOL PATHWAY ACTIVITY IN DIABETIC HYPERGLYCEMIA AND GALACTOSEMIA

被引：35

作者：

SEGAWA, M

HIRATA, Y

FUJIMORI, S

OKADA, K

机构：

来源：

METABOLISM-CLINICAL AND EXPERIMENTAL | 1988年 / 37卷 / 05期

关键词：

D O I：

10.1016/0026-0495(88)90046-7

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：454 / 460

页数：7

共 34 条

[1]

AKAGI Y, 1983, INVEST OPHTH VIS SCI, V24, P257

[2]

ALGVERE P, 1968, ACTA OPHTHALMOL, V46, P993

[3]

Bergmeyer HU, 1974, METHOD ENZYMAT AN, P1205

[4] ELECTRORETINOGRAM - ITS COMPONENTS AND THEIR ORIGINS [J].

BROWN, KT .

VISION RESEARCH, 1968, 8 (06) :633-+

[5] POLYOL ACCUMULATION IN GALACTOSEMIC AND DIABETIC RATS - CONTROL BY AN ALDOSE REDUCTASE INHIBITOR [J].

DVORNIK, D ;

SIMARDDU.N ;

KRAMI, M ;

SESTANJ, K ;

GABBAY, KH ;

KINOSHITA, JH ;

VARMA, SD ;

MEROLA, LO .

SCIENCE, 1973, 182 (4117) :1146-1148

[6] EXPERIMENTAL GALACTOSEMIA PRODUCES DIABETIC-LIKE RETINOPATHY [J].

ENGERMAN, RL ;

KERN, TS .

DIABETES, 1984, 33 (01) :97-100

[7]

FROSTLARSEN K, 1983, DIABETOLOGIA, V24, P207

[8]

FUJIMORI S, IN PRESS J MED CHEM

[9] NERVE-CONDUCTION DEFECT IN GALACTOSE-FED RATS [J].

GABBAY, KH ;

SNIDER, JJ .

DIABETES, 1972, 21 (05) :295-&

[10]

GREEN RJ, 1985, DIABETOLOGIA, V28, P104

← 1 2 3 4 →